Funding

#Biotech #Drug discovery #Funding #Investment #UK

Early-stage biotech investment: where are we? 

Yogan A Patel, Partner at MHA and Head of MHA’s Pharma, Life Science and Med-Tech sector group examines the investment landscape for early-stage biotech companies in the UK and further afield.   It is well recognised by both investors and government that the UK has huge strengths in biotechnology. Investment… Read More

#Exclusive Content

GBP pound sterling funding
#Funding #Innovate UK #Nuclera #Proteins

Nuclera receives £1.14m for eProtein Discovery platform

Biotech Nuclera has been awarded two Innovate UK grants totalling £1.14 ($1.4) million to further develop its eProtein Discovery platform. The funding is made up of a flexible, agile, scalable, and sustainable technologies (FASST) grant awarded in collaboration with DeepMirror, and an Engineering Biology grant. Read More

#News

Neurons in a brain with Alzheimer's disease
#Alchemab Therapeutics #Funding #Neuroscience #Parkinson's #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

Novel antibody with potential in Parkinson’s disease  

Alchemab Therapeutics has been awarded a grant of $595,000 by The Michael J Fox Foundation for Parkinson’s Research (MJFF) to support its Parkinson’s disease (PD) programme.  The grant will fund research performed at Alchemab following its identification of antibodies that target prostaglandin biology in PD, a potentially unique… Read More

#News

#AI / data analytics / healthtech / informatics #Carbon emissions #Climate change #Clinical trial design #Comment #Funding #Life sciences #Pharma #Psychedelics #Start-ups

Podcast: The future climate and landscape for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “The future climate and landscape for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Pharma’s important climate and What will the… Read More

#News

Antibody drug conjugate
#Antibodies #Antibody drug conjugate (ADC) #Cancer research #Funding #Pheon Therapeutics #Solid tumours

$120m raised to develop differentiated ADC pipeline 

Pheon Therapeutics has completed a $120m Series B financing to fund the development of its pipeline of next generation ADCs for a wide range of hard-to-treat cancers.  The new financing will be used to further advance Pheon’s differentiated ADC pipeline through clinical proof of concept. The first three assets are… Read More

#Business & Investment #Cancer Research #News

Neurons in a brain with Alzheimer's disease
#Alzheimer's #Funding #Neurodegenerative disorders #Private investment #University of Texas

$20 million donation supports neurodegeneration research

The University of Texas MD Anderson Cancer Center has been awarded $20 million to strengthen neurodegeneration research. The donation was awarded to the Belfer Neurodegeneration Consortium (BNDC), which aims to develop five new medicines for Alzheimer’s disease and related disorders over the next 10 years, with… Read More

#News

Great British Pounds, Investment
#Drug discovery #Funding #Investment

UK drug discovery needs stronger funding effort, report shows 

Improvements to the ways medicines are discovered are essential for the future health of patients, a new report by Medicines Discovery Catapult (MDC) shows.   The State of the Discovery Nation (SODN) 2024: ‘Fostering a Dynamic, Sustainable Medicines Discovery Sector’ report states that the industry must… Read More

#News

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

New DDW Highlights episode: 8 May 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The ongoing innovation and development in the drug discovery sector relies on a number… Read More

#News

#Allogene Therapeutics #allogeneic cell therapies #Biologics #Biotech #Cancer Research Horizons #Cancer vaccine #CAR-T #Cell therapy #Clinical trials #Drug discovery #Financing #Funding #LifeArc #Oncology #Rare disease #Research and development #Seed funding #Start-ups #University of Dundee #University of Oxford

This week in drug discovery (29 April – 3 May) 

News round-up for 29 April – 3 May by DDW Multimedia Editor Megan Thomas. The ongoing innovation and development in the drug discovery sector relies on a number of moving parts, one of which is financial support and backing. Whether it is successful seed funding or dedicated investment,… Read More

#News

business deal
#Drug discovery #Funding #Mergers and acquisitions #Obesity #Oncology

Reflections from LSX World Congress 

DDW Editor Reece Armstrong and Multimedia Editor Megan Thomas attended LSX World Congress from 29-30 April in London, UK. Having attended a range of sessions and spoken to industry attendees, they reflect on the biotech arm of the event.   Day One  The morning of LSX was punctuated by investment sessions… Read More

#Exclusive Content #News

CAR-T therapy
#Allogene Therapeutics #allogeneic cell therapies #CAR-T #Cell therapy #Funding #Oncology

$15 million CIRM grant supports allogeneic CAR-T in renal cell carcinoma

Allogene Therapeutics has received a $15 million grant from the California Institute for Regenerative Medicine (CIRM) to support the development of ALLO-316, an AlloCAR T investigational product for the treatment of advanced or metastatic renal cell carcinoma (RCC). ALLO-316 targets CD70, which is highly expressed in RCC and is also… Read More

#Business & Investment #News

#CN Bio #Funding #Investment #Organ-on-a-chip

CN Bio raises $21 million in Series B investment round

Organ-on-a-chip (OOC) company CN Bio has raised a $21 million investment in the first close of its Series B fundraising round. The funding has been secured from several new investors; including $10 million from Bayland Capital, and $5.5 million from founding shareholder, CN Innovations Holdings Ltd. The investment will be… Read More

#Business & Investment #News

University of Birmingham
#Academic #Drug discovery #Funding #Investment #Start-ups #University of Birmingham

Birmingham, UK, Drug Discovery Hub created

The Birmingham Drug Discovery Hub (BDDH) has been set up to help University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and commercial investment. The hub has attracted more than £4 ($4.9) million in… Read More

#News #Start-up Zone

#Confo Therapeutics #Endocrinology #Funding #GPCRs #Metabolomics

€1.6m grant supports drug discovery in metabolic diseases

Confo Therapeutics has been awarded a €1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The two-year grant will be used to expand Confo’s R&D efforts in the discovery of new medicines targeting Class B G protein-coupled receptors (GPCRs) using its patent-protected technology platform. Read More

#News

Blood cells
#Biotechnology #Collaboration #Funding #Haematology #Hemostatics

Validating a revolutionary therapy against lethal haemorrhage 

A public-private consortium formed by the biotech Hemostatics, based at the Barcelona Science Park, the Clínica Universidad de Navarra (CUN) and the Institute of Chemical Research of Catalonia (ICIQ), has received €2.5 million from the Spanish Research Agency (AEI), under the call for grants for Public-Private Collaboration Projects, to… Read More

#News

Genomics
#Funding #Genetics / genomics #Snow Medical Research Foundation #University of Queensland

$8 million awarded to landmark genetic research project

Landmark genetic research could allow doctors to accurately predict whether a patient is at risk of developing common diseases, decades before any symptoms would become evident. Snow Medical Research Foundation has awarded University of Queensland (UQ) researchers $8 million to dramatically advance the use of genomics… Read More

#News